These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Newborn screening for spinal muscular atrophy in Osaka -challenges in a Japanese pilot study. Kimizu T; Ida S; Oki K; Shima M; Nishimoto S; Nakajima K; Ikeda T; Mogami Y; Yanagihara K; Matsuda K; Nishi E; Hasegawa Y; Nozaki M; Fujita H; Irie A; Katayama T; Okamoto N; Imai K; Nishio H; Suzuki Y Brain Dev; 2023 Aug; 45(7):363-371. PubMed ID: 36973114 [TBL] [Abstract][Full Text] [Related]
13. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Feldkötter M; Schwarzer V; Wirth R; Wienker TF; Wirth B Am J Hum Genet; 2002 Feb; 70(2):358-68. PubMed ID: 11791208 [TBL] [Abstract][Full Text] [Related]
14. Incorporating Spinal Muscular Atrophy Analysis by Next-Generation Sequencing into a Comprehensive Multigene Panel for Neuromuscular Disorders. Tan CA; Westbrook MJ; Truty R; Kvitek DJ; Kennemer M; Winder TL; Shieh PB Genet Test Mol Biomarkers; 2020 Oct; 24(10):616-624. PubMed ID: 32721234 [No Abstract] [Full Text] [Related]
15. Combination of SMN2 copy number and NAIP deletion predicts disease severity in spinal muscular atrophy. Watihayati MS; Fatemeh H; Marini M; Atif AB; Zahiruddin WM; Sasongko TH; Tang TH; Zabidi-Hussin ZA; Nishio H; Zilfalil BA Brain Dev; 2009 Jan; 31(1):42-5. PubMed ID: 18842367 [TBL] [Abstract][Full Text] [Related]
17. PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan. Noguchi Y; Bo R; Nishio H; Matsumoto H; Matsui K; Yano Y; Sugawara M; Ueda G; Wijaya YOS; Niba ETE; Shinohara M; Bouike Y; Takeuchi A; Okamoto K; Saito T; Shimomura H; Lee T; Takeshima Y; Iijima K; Nozu K; Awano H Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421785 [TBL] [Abstract][Full Text] [Related]
18. Multiplex Droplet Digital PCR Method Applicable to Newborn Screening, Carrier Status, and Assessment of Spinal Muscular Atrophy. Vidal-Folch N; Gavrilov D; Raymond K; Rinaldo P; Tortorelli S; Matern D; Oglesbee D Clin Chem; 2018 Dec; 64(12):1753-1761. PubMed ID: 30352867 [TBL] [Abstract][Full Text] [Related]
19. The analysis of the association between the copy numbers of survival motor neuron gene 2 and neuronal apoptosis inhibitory protein genes and the clinical phenotypes in 40 patients with spinal muscular atrophy: Observational study. Zhang Y; He J; Zhang Y; Li L; Tang X; Wang L; Guo J; Jin C; Tighe S; Zhang Y; Zhu Y; Zhu B Medicine (Baltimore); 2020 Jan; 99(3):e18809. PubMed ID: 32011487 [TBL] [Abstract][Full Text] [Related]
20. [Newborn screening program for spinal muscular atrophy]. Kölbel H; Vill K; Schwartz O; Blaschek A; Nennstiel U; Schara-Schmidt U; Hoffmann GF; Gläser D; Röschinger W; Bernert G; Klein A; Müller-Felber W Nervenarzt; 2022 Feb; 93(2):135-141. PubMed ID: 34652481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]